- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03876782
Level of Agreement of Intraocular Lens Power Measurements Between IOLMaster and Verion
March 14, 2019 updated by: Georgios Labiris, Democritus University of Thrace
Primary objective of this study is to evaluate the level of agreement of two keratometry modules, the IOLMaster and the Verion Reference Unit, in terms of keratometric values and IOL power calculation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Participants were enrolled from the Cataract & Presbyopia Service of the University General Hospital of Alexandroupolis in a consecutive-if-eligible basis.
Apart from keratometric values, IOL power calculations will be compared for 8 IOL models (Acrysof SN60WF, SN60AT, SN6ATx, TFNT00, TFNTx0, SV25T0, SV25Tx and Tecnis ZCB00) using 4 formulas (SRK/T, Holladay 1, Hoffer Q and Haigis).
Study Type
Observational
Enrollment (Actual)
54
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Evros
-
Alexandroupolis, Evros, Greece, 68100
- University Hospital of Alexandroupolis
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Cataract patient that visit the Cataract Outpatients Service of the University Hospital of Alecxnadroupolis
Description
Inclusion Criteria:
- Senile Cataract
Exclusion Criteria:
- Former incisional surgery,
- Corneal diseases,
- Dry-eye-Disease,
- Glaucoma drops,
- Inability to obtain accurate measurements.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
IOLMaster group
IOL power for all cataract participants will be measured with IOLMaster and Verion
|
IOL power calculation will be done with IOLMaster
IOL power calculation will be done with Verion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
IOL Power Calculation
Time Frame: 1 day prior to surgery
|
Exact calculation of dioptric power of the intraocular lens
|
1 day prior to surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 15, 2017
Primary Completion (Actual)
December 15, 2018
Study Completion (Actual)
December 15, 2018
Study Registration Dates
First Submitted
March 12, 2019
First Submitted That Met QC Criteria
March 14, 2019
First Posted (Actual)
March 15, 2019
Study Record Updates
Last Update Posted (Actual)
March 15, 2019
Last Update Submitted That Met QC Criteria
March 14, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Th9/ES2/22-2-19
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Colvard Kandavel Eye CenterEnrolling by invitationCataract | Cataract Bilateral | Cataract Surgery | Cataract (Post-operative Cataract Surgery Follow-up)United States
-
Matthew RauenNot yet recruitingNuclear Cataract | Cataract Surgery Anesthesia | Cataract and IOL Surgery | Cataract Surgery ExperienceUnited States
-
Züleyha SönmezAtaturk UniversityActive, not recruitingCataract Surgery | Cataract Patients | Cataract After SurgeryTurkey (Türkiye)
-
Stanford UniversityEnrolling by invitationIntraocular Lens | Cataract Extraction | Cataract Surgery | Eye Disorders | Cataract and IOL Surgery | Cataract Surgery ExperienceUnited States
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Nicole Fram M.D.RecruitingCataract Bilateral | Nuclear Sclerosis of the Lens | Phacoemulsification Cataract SurgeryUnited States
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Seva Canada SocietyPragyaan Sustainable Health Outcomes Foundation; Sadgura Netra ChikitsalayaNot yet recruitingCataract (Post-operative Cataract Surgery Follow-up)
-
Centre hospitalier de l'Université de Montréal...Not yet recruitingCataract | Cataract Bilateral | Cataract Surgery
Clinical Trials on IOLMaster
-
OFTALVIST (Oftalmología Vistahermosa S.L)Completed
-
Advanced Vision CareClinical Research Consultants, Inc.Completed
-
Multack Eye CareCompleted
-
Berkeley Eye CenterAlcon ResearchCompleted
-
Mahidol UniversityCompleted
-
Ziemer Ophthalmic Systems AGCompleted
-
Cylite Pty LtdCompletedNormal Eyes | Abnormal EyesUnited States
-
Peking University Third HospitalNot yet recruiting
-
Democritus University of ThraceCompletedCataract | Presbyopia | Intraocular Lens | Ocular BiometryGreece
-
Prim. Prof. Dr. Oliver Findl, MBACompleted